Marshall Wace North America’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-24,261	Closed	-$500K	–	1431
2021 Q1	$500K	Sell	24,261 -1,257,363	-98%	-$25.9M	﹤0.01%	1172
2020 Q4	$22.5M	Buy	1,281,624 +1,026,901	+403%	+$18M	0.1%	230
2020 Q3	$3.78M	Buy	+254,723	New	+$3.78M	0.02%	449